FluGen’s Intranasal M2SR Flu Vaccine, Co-Administered with High Dose Vaccine, in Older Adults Shows Superiority Over Flu Shot Alone Combining FluGen's M2SR nasal spray flu vaccine with Sanofi's Fluzone High Dose shot generates superior results in older adults versus the shot alone.

Global Influenza Vaccine Market Analysis & Forecast Report 2024: Advanced R&D Initiatives Poised to Catalyze Growth Through 2034 Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Influenza Vaccine Market Analysis & Forecast 2024-2034: Market By Vaccine Type; By Indication; By Age Group; By Route of Administration; By...

FLUBLOK: A Quadrivalent Influenza Vaccine for Adults Aged 18 and Older - Drug Insights and Market Forecast to 2032 Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "FLUBLOK QUADRIVALENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This "FLUBLOK QUADRIVALENT...

Fluzone Quadrivalent Drug Insights and Market Forecasts, 2019-2022 & 2023-2032 Dublin, Nov. 24, 2023 (GLOBE NEWSWIRE) -- The "FLUZONE QUADRIVALENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report offers...

Seasonal Influenza Vaccines Market Report 2020: Flucelvax QIV and Flublok QIV are Expected to Experience Sales Growth Following Anticipated Regulatory Approvals in the EU in Q4 2020 Dublin, Dec. 04, 2020 (GLOBE NEWSWIRE) -- The "Seasonal Influenza Vaccines" report has been added to ResearchAndMarkets.com's offering. The seasonal influenza vaccines market in the US, Japan, and...